Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Current Leases (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Current Leases for 5 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 34.03% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, down 34.03% year-over-year, with the annual reading at $2.3 million for FY2025, 34.03% down from the prior year.
  • Current Leases hit $2.3 million in Q4 2025 for Kezar Life Sciences, down from $3.3 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $3.8 million in Q2 2025 to a low of $1.1 million in Q1 2021.
  • Historically, Current Leases has averaged $2.4 million across 5 years, with a median of $2.7 million in 2023.
  • Biggest five-year swings in Current Leases: soared 117.83% in 2023 and later tumbled 34.03% in 2025.
  • Year by year, Current Leases stood at $1.2 million in 2021, then skyrocketed by 113.93% to $2.6 million in 2022, then grew by 17.43% to $3.0 million in 2023, then increased by 17.07% to $3.5 million in 2024, then crashed by 34.03% to $2.3 million in 2025.
  • Business Quant data shows Current Leases for KZR at $2.3 million in Q4 2025, $3.3 million in Q3 2025, and $3.8 million in Q2 2025.